Year : 2020  |  Volume : 23  |  Issue : 3  |  Page : 351--353

Repeat reteplase therapy in a patient with recurrent prosthetic tricuspid valve thrombosis after trido multiple valve replacement


Hasan Haghaninejad, Somaye Fallahzade, Mohammadreza Pagardkar 
 Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Correspondence Address:
Mohammadreza Pagardkar
Cardiovascular Research Center, Afshar Hospital, Jomhouri Blvd., Yazd
Iran

Prosthetic valve thrombosis (PVT) is a rare but life-threatening complication. It has an incidence of 6.1% in developing countries and 0.3%–1.3% in developed countries. The first-line treatment for the right-sided PVT is fibrinolytic therapy with streptokinase or recombinant tissue plasminogen activators, but there are limited cases that were treated with recombinant plasminogen activators. A 57-year-old female with a history of Trido valve surgery and persistent atrial fibrillation rhythm was hospitalized for recurrent tricuspid mechanical valve thrombosis multiple times. The patient was treated with fibrinolytics successfully three times. We report a rare case of recurrent tricuspid mechanical valve thrombosis that is treated with IV reteplase twice.


How to cite this article:
Haghaninejad H, Fallahzade S, Pagardkar M. Repeat reteplase therapy in a patient with recurrent prosthetic tricuspid valve thrombosis after trido multiple valve replacement.Ann Card Anaesth 2020;23:351-353


How to cite this URL:
Haghaninejad H, Fallahzade S, Pagardkar M. Repeat reteplase therapy in a patient with recurrent prosthetic tricuspid valve thrombosis after trido multiple valve replacement. Ann Card Anaesth [serial online] 2020 [cited 2020 Nov 27 ];23:351-353
Available from: https://www.annals.in/article.asp?issn=0971-9784;year=2020;volume=23;issue=3;spage=351;epage=353;aulast=Haghaninejad;type=0